Amgen recognizes the importance of sound public policy in achieving our goal of serving patients by providing therapies that have the power to restore health or even save lives. Accordingly, Amgen participates in the political process and supports those candidates, committees, and other organizations who work to advance healthcare innovation and improve patient access.
Although federal law prohibits corporations from making contributions in federal elections, a corporation may administer a political action committee (“PAC”) for its employees. Amgen employees may participate in the political process through Amgen PAC.
State and Local Elected Offices
The Government Affairs department regularly updates the Corporate Responsibility and Compliance Committee of the Board of Directors on political and public policy issues of importance to Amgen. As part of its oversight role, that Committee annually reviews Amgen’s policies, practices, and overall philosophy for making political contributions. Contributions are audited on a regular basis and made in accordance with company policies approved by senior management, who are charged with administering those policies and ensuring compliance with them. The Amgen Board of Directors recognizes that the use of Amgen’s resources in the political process is an important issue for stockholders.
To improve access to information about Amgen’s corporate political contributions in the United States, Amgen posts, on a semi-annual basis, our contributions categorized by state, candidate, and amount.
Amgen has not used corporate funds to make any direct independent expenditures on behalf of candidates running for public office. If Amgen makes independent expenditures in the future, these contributions would be disclosed, as are other corporate political contributions, via the semi-annual disclosure reports posted below.
Reports containing our political contributions can be found at the following links:
Also on a semi-annual basis, Amgen discloses political action committee contributions made to candidates and organizations in compliance with the U.S. Congress’s Honest Leadership and Open Government Act (HLOGA), at this address. (To view Amgen’s disclosures, select “registrant name (returns registrant filings only)” and select “submit.” Then enter “Amgen Inc” in the registrant name box and select “submit.”)
Last updated on: Jan 31, 2013